I am
really not much of a political person. I don’t like politics,
mainly because I do not like it when people are not honest. And politicians
are rarely honest. They can convince themselves that they mean to
be honest, but expediency usually wins out. Having said that, I could
not be a politician because there are too many hard choices to make.
How do you spend $100? On education? On health? On new roads? Give
it to starving people in the third world? I could not decide this,
so my solution is to avoid politics as much as possible.
But not
today. The world of ME/CFS is in chaos in this country. It is getting
better in other countries. So I would like to devote some of this
issue of the Lyndonville News toward politics
and activism. Without voices like yours, ME/CFS will stay an invisible
illness.
History
ME/CFS
has been around in the “modern world” since a 1938 outbreak
in Los Angeles. There have been over 50 recorded outbreaks or clusters,
and well over 1,000 scientific papers on it in recent years. Yet it
remains unknown, scorned, doubted and ridiculed. Persons with this
illness face daily discrimination, perhaps a greater condemnation
of our societal beliefs than anything else. As a country, we consider
ourselves compassionate and religious, yet we are so obsessed with
increasing our personal wealth that we easily neglect the education
of our children, the basic needs of the poor, and the health of the
sick. If you can’t tell, I just read a book on the Sermon on
the Mount.
The most
effective way to continue the apathy which the ME/CFS world experiences
is to get into more arguments with ourselves. Lets condemn the CFIDS
Association or the NCF. Lets fight over the name, lets…
One thing
that ME/CFS patients have never learned is that they do not have enough
energy to fight each other and do something constructive. So, after
a few years they burn out and disappear. Not many years ago there
were lots of state organizations, hundreds of support groups. Now?
Everything is so quiet. It's not about money, it's about will and
determination.
There
are some patients who are ready to do whatever is necessary to help
government (CDC, NIH) and the medical world tackle ME/CFS. They are
the 40 year old women and men with CFS who are seeing the signs of
the illness in their children. The NIH and CDC say that this illness
does not run in families. Every clinician who studies ME/CFS knows
that it does. Not all children get it, but a lot do. Those parents
with the illness who see it developing in their children have extra
motivation to do something about it.
There
are probably six known genes that could be involved in ME/CFS (see
below). Is the NIH studying it? I have fifteen families in my practice
where parent and children are ill. Anyone out there want their blood?
Why is this not important – and don’t say its because
of subtleties in the diagnostic criteria. I think that is merely an
excuse to do nothing. I would say to the CDC, pick your criteria and
study it. To the NIH – fund some studies. You complain that
there is no proof, but no one will put up the money to do a study.
By the way, I just read that the NIH has funded five Botanical Research
Centers for five years each to look at botanicals from flaxseed to
tarragon.
This
is one of the great advances of “evidence-based medicine.”
A study on high blood pressure (ALLHAT) cost 300 million dollars and
found out that high blood pressure is bad for you. Wonderful. Evidence-based
medicine is a concept that increases corporate income because it increases
sales of drugs – more people will take ACE inhibitors for their
blood pressure. But it also ensures that nothing new or complicated
can be studied. Sounds like sour grapes from a clinician, medical
observations are not worth much anymore.
I
am not suggesting that the treatment for high blood pressure not be
improved. I am suggesting that the enormous personal and societal costs
of invisible illnesses should no longer be ignored.
What
do you do? If you are a patient, figure out something to do that you
can do with your meager allocation of energy. Maybe write a letter.
Or write a letter every day (Florence Nightingale did that.) Change
the name. Or have a support group meeting. Or have a fundraiser. Support
a national patient organization, or two or three. They don’t
have to be clones of each other. But do something, if you can.
And if
you are getting better, be grateful, but don‘t forget about
ME/CFS. I just talked with a young lady whom I had not seen for nearly
eighteen years. She got better, almost. But like many persons who
almost get better, she did not recover and then began to slide again.
For ten years she could forget about the illness, but not any longer.
Sorry to be discouraging, but the time has come – we have to
do something about this horrible illness. I believe it is both curable
and preventable, someday.
Appendix
Genes
that may play an important role in ME/CFS, partial listing:
1. Polymorphism in PON1 gene encoding paraoxonase/arylesterase, an enzyme
that hydrolyzes organophosphate poisons to harmless products (Haley
R, Billecke S, La Du B. Association of low PON1 type Q (Type A) arylesterase
activity with neurologic symptom complexes in Gulf War veterans. Toxicol
Appl Pharmacol 1999;157:2129-2137).
2. Familial corticosteroid-binding globulin deficiency, due to null
mutation in globulin gene (Torpy D, Bachmann A, Grice J, Fitzgerald
S, Phillips P, Whitworth J, et al. Familial corticosteroid-binding globulin
deficiency due to a novel null mutation: association with fatigue and
relative hypotension. J Clin Endocrinol Metab 2001;86:3692-3700.
3. Hypofunction of 5-HT system due to long allelic variants in the serotonin
transporter (5-HTT) gene promoter (Narita M, Nishigami N, Narita N,
Yamaguti K, Okado N, Watanabe Y, et al. Association between serotonin
transporter gene polymorphism and chronic fatigue syndrome. Biochemical
and Biophysical Research Communications 2003;311:264-266.
4. Myoadenylate deaminase (AMPD1) mutation cause of myopathy.
6. I/D polymorphism in ACE gene (DCP1) (Vladutiu G, Natelson B. Association
of medically unexplained fatigue with ACE insertion/deletion polymorphism
in Gulf War verterans. Muscle Nerve 2004;30:38-43.)
7. Polymorphism of the corticosteroid binding globulin Ser/Ala 224 (Torpy
D, Bachmann A, Gartside M, Grice J, Harris J, Clifton P, et al. Association
between chronic fatigue syndrome and the corticosteroid-binding globulin
gene ALA SER 224 polymorphism. Endocrine Research 2004;30(3):417-429.
American
Association for CFS (AACFS)
The AACFS
has now been in existence for over a decade. It is a scientific association
devoted to furthering the science and provision of medical care to
persons with ME/CFS. It is a good organization. Its heart is in the
right place. It has made mistakes, it is weak, it is too soft-spoken,
it is too complacent…yes, there have been lots of difficulties.
It could be better, and hopefully it is getting better.
It is
run by Dr. Nancy Klimas, president, Dr. Leonard Jason, vice president,
Dr. Lucinda Bateman, secretary, Dr. Dharam Ablashi, past president,
and the Board of Directors which I happen to be on. Other board members
come from Japan, Sweden, and Belgium, so it is not just yanks. I do
not think it should be called the American Association for CFS. All
board members are volunteers, and I think it should stay that way.
It used to be that only professionals such as physicians and researchers
could be members, but that is now changed and members of the public
are invited. And we need input and help from members of the public.
Most
illnesses have professional societies that are devoted to study, teaching,
fundraising, and awareness. The MS society is very powerful, influencing
the direction of millions of dollars in research. American Heart Association,
American Cancer Society… These organizations have done more
for the illnesses they serve than anyone could have ever imagined.
We need this kind of help/activism in ME/CFS. The organization really
started from the financial contribution of Governor Rudy Perpich.
A conference is held every two years, and other events are held if
possible in between. The AACFS newsletter is by e-mail only and is
directed toward clinicians in an attempt to improve patient care.
It may be informative for members of the public, but it is directed
toward clinicians.
Now we
need the help of the patient organizations and the patients themselves.
We need funds, suggestions, organizational leadership, new ideas.
If you wish to become an individual supporting member it is $40 and
you would receive their newsletter for one year. If you have tons
of money you could send more. We need you. Anyone interested can call
or e-mail
or
write to 27 N. Wacker Dr. 416 in Chicago, Ill, 60606. Lets put ME/CFS
on the map, and not allow it to languish on the periphery as a disreputable
form of hypochondriasis.
Literature
Review
Antibodies
to the Muscarinic Acetylcholine Receptor in CFS. Presented In: International
Conference on Fatigue Science 2005; Karuizawa, Japan, 2005. David E.
Bell, BS, Aristo Vojdani, PhD, David S. Bell, MD
Background
Patients
with chronic fatigue syndrome experience severe fatigue, orthostatic
intolerance and numerous other symptoms that are similar to known
illnesses of the autonomic nervous system. Because of these similarities
it is possible that disruption of autonomic nervous system nerve transmission
may play a role in the symptoms of the illness. In a recent paper,
researchers noted that 50% of patients with CFS had antibodies to
the muscarinic acetylcholine receptor (Tanaka S, et al. Autoantibodies
against muscarinic cholinergic receptor in chronic fatigue syndrome.
Int J Mol Med 2003;12:225-230.) The presence of an autoimmune dysautonomia
with autoantibodies to the muscarinic acetylcholine receptor is a
theoretical etiology for some patients with CFS. If autoimmune dysautonomia
exists and can be effectively recognized, therapeutic implications
for this group of patients may be developed. Objective:
The present study was designed to examine IgG, IgM, and IgA antibodies
to the neuromuscular acetylcholine receptors (AR) and to muscarinic
receptors (MR) in patients with chronic fatigue syndrome (CFS) and
healthy matched controls. Methods: Twenty five adults
with CFS were matched with healthy community controls for age and
sex. After informed consent, venous blood samples were drawn and sent
to Immunosciences Laboratory in a blinded manner. The testing procedure
was the same as previously described. Results: Five
of the antibodies studies (IgA_AR; IgM_AR; IgG_AR; IgM_MR; and IgG_MR)
showed no differences between patients and controls. However the IgA_MR
was statistically higher in patients than in controls (0.43 vs. 0.33,
p = 0.031). Conclusions: Our studies are in agreement
with the studies of Tanaka et al (1) that autoantibodies against muscarinic
receptors may be an important marker in a group of patients with CFS.
Further studies should be undertaken to further characterize these
autoantibodies and to determine specifics of the subgroup to which
they may apply. If this proves to be a consistent finding, therapy
directed toward the acetylcholine neurotransmitter system may be of
benefit in this group of patients.
Rookie
Section and comment
What
does this mean? First of all, the above paper was presented at a conference
and discussion was held around the poster. A manuscript is being prepared
for publication, but it has not been published. It is exciting, but
in medical research, things move very slowly.
In an
earlier Lyndonville News, I reviewed Tanaka’s
paper (Lynnews 1:3). His paper is suggesting that ME/CFS is an autoimmune
dysautonomia, and our paper is in agreement. So, what exactly is an
autoimmune disease?
Autoimmune
diseases, (for example multiple sclerosis, rheumatoid arthritis, lupus,
etc.) are illnesses where a person’s own body attacks themselves.
It is an immune system with suicidal tendencies. Auto = self, immune
= immune reaction. It is a person’s immune system allergic to
itself. In rheumatoid arthritis, the body attacks its own joint tissue.
In MS, it attacks the brain. Most persons with hypothyroidism are so
because the body destroyed its own thyroid gland, and so on.
Old-Timer’s
Section (Graduate Studies)
Persons
with certain types of illnesses are more likely to develop autoimmune
diseases. Certain infectious diseases are known to set off immune
system problems. Strep causes rheumatic fever, parvovirus causes fatigue
and joint pain. And there are many others. There are several known
mechanisms, one of which is molecular mimicry. In this mechanism,
a virus or bacteria has a section that looks much like normal body
tissue. The immune system then develops antibodies against the infectious
agent but these antibodies then attack the body as well.
The biggest
problem in assessing autoimmunity such as suggested by the muscarinic
receptor autoantibody study mentioned above is to know whether the
autoantibody is actually causing the problem or if it just happed
to be there. For example, 25% of ME/CFS patients have a positive Antinuclear
antibody (ANA) but they do not have lupus. The presence of this antibody
in such high numbers in ME/CFS could hint toward the fact that ME/CFS
patients are more prone to developing other antibodies. Lots of work
to be done in this area.
Lyndonville
Research Group Report
A number
of questions have come in regarding the LRG, what it is, and what
we do. We are a group of odd, disparate persons, many of us in the
throes of a mid-life identity crisis, seeking to help the ME/CFS/FM
cause in one way or another. At present we number roughly ten people,
but the number varies dependent upon everyone’s circumstances:
presence or absence of a relapse, other life stresses, or the waning
or waxing of enthusiasm. We like to think of our group as rather “fluid”.
People
who volunteer to the LRG bring the skills that they possess. One person
may be a scientist, another person may be a ‘gofer’. For
those of you who do not know about the “gofers” in medical
research, they are the most important members of the team. They go-fer
stuff. For example, one study we recently did involved pulling out
every record of persons with ME/CFS/FM who had a blood volume study.
This was, of course, done by the “gofers”, and I was one
of them. My particular role that evening was to “go-fer”
the pizza. The data that we collected in this study was presented
at the AACFS meeting in October in Madison, Wisconsin. It is a nice
little clinical study. Not earth shattering, not brand new, but a
few observations about a packet of clinical experience we have accumulated
in the office. All-in-all, we have about five projects that are in
various states of disrepair.
Our budget
is limited. So far it comes to roughly twenty six dollars spent entirely
for pizza. In future issues of the Lyndonville News
I would hope to describe some of the specific projects. They may not
be good enough to publish in a medical journal but they are interesting.
Recently,
the LRG has been more active. One project has been to draw and send
blood samples, as well as score the questionnaires on the muscarinic
acetylcholine studies which were presented above. We are working on
a couple of papers for publication, as no one will ever believe something
that has not been published. It's like the Turkish astronomer in The
Little Prince.
Another
area of concentration is the school nurse project. We have completed
two lectures to school nurses at different meetings, and have another
scheduled. I see this as very urgent because school nurses are in
a position to help young persons with ME/CFS almost more than anyone
else. The school nurse is in a position to influence the school administration,
psychologists, and physicians, which will hopefully lead to better
overall management. I know of several instances where the diagnosis
of ME/CFS was first made by the school nurse and only reluctantly
later on by the pediatrician.
We had
a lovely evening at the Stages concert, and they very kindly donated
the proceeds of the event to the LRG. There have been a few other
donations as well and we are very grateful. More pizza at our meetings.
Actually, I am reluctant to even talk about this because we do not
need lots of money. We seem to be doing pretty well as a volunteer
organization, and I am nervous of the responsibility of accepting
the hard earned money of people who are broke. I cannot know if our
use of donations will be worth productive. I certainly hope they will
be, and we are sincere, but who knows? The first donation I ever received
for a CFS study (a big donation) was given to a researcher for an
important study. The researcher bought a fancy computer, then didn’t
do the study for many years. When the study was finally published,
it was irrelevant. This is another reason I could never be a politician.
Question
and Answer
Can
you tell me if orthostatic intolerance causes breathlessness on standing
and is there any mechanism through which diazepam could help this?
Good
question. Orthostatic intolerance certainly causes breathlessness,
and this symptom is often mistaken for asthma in patients with ME/CFS.
One easy way to tell the difference is that the asthma medicines do
not work. The cause of the breathlessness is probably a reduction
in blood flow through the heart and lungs, but this may be different
for every “type“ of CFS. I have definitely noticed benzodiazepines
(Valium® or Xanax®) help this symptom but do not know why.
The usual answer is that it reduces the respiratory rate by reducing
anxiety, and the reduced respiratory rate improves carbon dioxide
balance. But I have my doubts that this is correct. It is related
to the observation that patients with ME/CFS cannot hold their breath
as long as healthy people. This was first noted by Dr. Paul Cheney,
but I have never been happy with the explanations I have heard to
attempt to explain it.
To
Subscribe:If you wish to either subscribe or unsubscribe
to the Lyndonville News, go to www.DavidSBell.com/DSBJoin.htm and
follow the instructions.
Disclaimer:
Any medical advice that is presented in the Lyndonville News is generic and for general informational
purposes only. ME/CFS/FM is an extremely complex illness and specific
advice may not be appropriate for an individual with this illness. Therefore,
should you be interested or wish to pursue any of the ideas presented
here, please discuss them with your personal physician.